title: Preliminary results with administration of recombinant human erythropoietin in sickle cell/beta-thalassemia patients during pregnancy.
authors.forename: K
authors.initials: K
authors.lastname: Bourantas
authors.forename: G
authors.initials: G
authors.lastname: Makrydimas
authors.forename: J
authors.initials: J
authors.lastname: Georgiou
authors.forename: S
authors.initials: S
authors.lastname: Tsiara
authors.forename: D
authors.initials: D
authors.lastname: Lolis
mesh_terms: D000293:Adolescent; D000328:Adult; D000755:Anemia, Sickle Cell / Q000188:drug therapy*; D004921:Erythropoietin / Q000627:therapeutic use*; D005260:Female; D005319:Fetal Hemoglobin / Q000378:metabolism; D006441:Hemoglobin A / Q000378:metabolism; D006801:Humans; D049590:Postpartum Period; D011247:Pregnancy; D011250:Pregnancy Complications, Hematologic / Q000188:drug therapy*; D011263:Pregnancy Trimester, Third; D011994:Recombinant Proteins / Q000627:therapeutic use; D017086:beta-Thalassemia / Q000188:drug therapy*
chemical_list: D011994:Recombinant Proteins; D004921:Erythropoietin; D006441:Hemoglobin A; D005319:Fetal Hemoglobin